These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2231336)

  • 1. Structure-pharmacokinetic relationships in a series of short fatty acid amides that possess anticonvulsant activity.
    Haj-Yehia A; Bialer M
    J Pharm Sci; 1990 Aug; 79(8):719-24. PubMed ID: 2231336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-pharmacokinetic relationships in a series of valpromide derivatives with antiepileptic activity.
    Haj-Yehia A; Bialer M
    Pharm Res; 1989 Aug; 6(8):683-9. PubMed ID: 2510141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic analysis and antiepileptic activity of tetra-methylcyclopropane analogues of valpromide.
    Bialer M; Hadad S; Kadry B; Abdul-Hai A; Haj-Yehia A; Sterling J; Herzig Y; Yagen B
    Pharm Res; 1996 Feb; 13(2):284-9. PubMed ID: 8932450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disposition of valpromide, valproic acid, and valnoctamide in the brain, liver, plasma, and urine of rats.
    Blotnik S; Bergman F; Bialer M
    Drug Metab Dispos; 1996 May; 24(5):560-4. PubMed ID: 8723737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic analysis of the structural requirements for forming "stable" analogues of valpromide.
    Haj-Yehia A; Hadad S; Bialer M
    Pharm Res; 1992 Aug; 9(8):1058-63. PubMed ID: 1409378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of a valpromide isomer, valnoctamide, in dogs.
    Haj-Yehia A; Bialer M
    J Pharm Sci; 1988 Oct; 77(10):831-4. PubMed ID: 3148708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic-pharmacodynamic relationships of (2S,3S)-valnoctamide and its stereoisomer (2R,3S)-valnoctamide in rodent models of epilepsy.
    Isoherranen N; White HS; Klein BD; Roeder M; Woodhead JH; Schurig V; Yagen B; Bialer M
    Pharm Res; 2003 Aug; 20(8):1293-301. PubMed ID: 12948028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The potential of sec-butylpropylacetamide (SPD) and valnoctamide and their individual stereoisomers in status epilepticus.
    Shekh-Ahmad T; Mawasi H; McDonough JH; Yagen B; Bialer M
    Epilepsy Behav; 2015 Aug; 49():298-302. PubMed ID: 25979572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of a valpromide isomer, valnoctamide, in healthy subjects.
    Bialer M; Haj-Yehia A; Barzaghi N; Pisani F; Perucca E
    Eur J Clin Pharmacol; 1990; 38(3):289-91. PubMed ID: 2111246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stereoselective anticonvulsant and pharmacokinetic analysis of valnoctamide, a CNS-active derivative of valproic acid with low teratogenic potential.
    Shekh-Ahmad T; Hen N; Yagen B; McDonough JH; Finnell RH; Wlodarczyk BJ; Bialer M
    Epilepsia; 2014 Feb; 55(2):353-61. PubMed ID: 24313671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacodynamic and pharmacokinetic analysis of CNS-active constitutional isomers of valnoctamide and sec-butylpropylacetamide--Amide derivatives of valproic acid.
    Mawasi H; Shekh-Ahmad T; Finnell RH; Wlodarczyk BJ; Bialer M
    Epilepsy Behav; 2015 May; 46():72-8. PubMed ID: 25863940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of antiepileptic isomers of valproic acid and valpromide in a rat model of neuropathic pain.
    Winkler I; Blotnik S; Shimshoni J; Yagen B; Devor M; Bialer M
    Br J Pharmacol; 2005 Sep; 146(2):198-208. PubMed ID: 15997234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the antiallodynic, teratogenic and pharmacokinetic profile of stereoisomers of valnoctamide, an amide derivative of a chiral isomer of valproic acid.
    Kaufmann D; Yagen B; Minert A; Wlodarczyk B; Finnell RH; Schurig V; Devor M; Bialer M
    Neuropharmacology; 2010 Jun; 58(8):1228-36. PubMed ID: 20230843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic considerations in the design of better and safer new antiepileptic drugs.
    Bialer M
    J Control Release; 1999 Nov; 62(1-2):187-92. PubMed ID: 10518650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stereoselective pharmacokinetic analysis and antiepileptic activity of N-2-hydroxypropyl valpromide, a central nervous system--active chiral valproylamide.
    Wasserman M; Yagen B; Blotnik S; Papo N; Bialer M
    Ther Drug Monit; 2001 Aug; 23(4):414-20. PubMed ID: 11477326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disposition of two tetramethylcyclopropane analogues of valpromide in the brain, liver, plasma and urine of rats.
    Blotnik S; Bergman F; Bialer M
    Eur J Pharm Sci; 1998 Apr; 6(2):93-8. PubMed ID: 9795021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and anticonvulsant activity of some substituted lactams and amides.
    Brouillette WJ; Grunewald GL
    J Med Chem; 1984 Feb; 27(2):202-6. PubMed ID: 6694169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis, physicochemical and anticonvulsant properties of some n-substituted amides of 3-spirocycloalkylpyrrolidine-2,5-dione.
    Obniska J; Zejc A
    Acta Pol Pharm; 2003; 60(5):383-90. PubMed ID: 15005422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and pharmacological evaluation of a new homologous series of (+/-)-p-fluoro-phenyl alcohol amide anticonvulsants.
    Carvajal-Sandoval G; Juárez-Carvajal E; Cruz-Peinado C; Meza-Toledo SE
    Arzneimittelforschung; 1998 Apr; 48(4):349-52. PubMed ID: 9608875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design and pharmacological activity of glycinamide and N-methoxy amide derivatives of analogs and constitutional isomers of valproic acid.
    Pessah N; Yagen B; Hen N; Shimshoni JA; Wlodarczyk B; Finnell RH; Bialer M
    Epilepsy Behav; 2011 Nov; 22(3):461-8. PubMed ID: 21959082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.